Report overview
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
This report aims to provide a comprehensive presentation of the global market for Cancer Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Treatment Drugs. This report contains market size and forecasts of Cancer Treatment Drugs in global, including the following market information:
Global Cancer Treatment Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cancer Treatment Drugs Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Cancer Treatment Drugs companies in 2022 (%)
The global Cancer Treatment Drugs market was valued at US$ 184060 million in 2022 and is projected to reach US$ 324170 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.
We surveyed the Cancer Treatment Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Treatment Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Cancer Treatment Drugs Market Segment Percentages, by Type, 2022 (%)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Global Cancer Treatment Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Cancer Treatment Drugs Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Global Cancer Treatment Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Cancer Treatment Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Treatment Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cancer Treatment Drugs revenues share in global market, 2022 (%)
Key companies Cancer Treatment Drugs sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Cancer Treatment Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Treatment Drugs, market overview.
Chapter 2: Global Cancer Treatment Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Cancer Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cancer Treatment Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
